 CAMBRIDGE, Mass., Dec. 01, 2021 GLOBE NEWSWIRE -- Codiak BioSciences, Inc. Nasdaq: CDAK, a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a new class of medicines, today announced that Douglas E. Williams, Ph.D., President and CEO, will participate in a virtual fireside chat at the 4th Annual Evercore ISI HealthCONx Conference. Details are as follows: 